21 Jul 2026 Logan Pharmaceuticals
Lower-carbon inhalers in the UK: why the 2026 MHRA approval matters
MHRA's July 2026 approval of lower-carbon beclometasone inhalers shows how medicine innovation now joins clinical, regulatory and sustainability planning.
Read article